These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases. Dabravolski SA; Bezsonov EE; Baig MS; Popkova TV; Orekhov AN Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203309 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Simon TG; Corey KE; Chung RT; Giugliano R Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510 [TBL] [Abstract][Full Text] [Related]
13. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
14. Interpreting lipoproteins in nonalcoholic fatty liver disease. Nemes K; Åberg F Curr Opin Lipidol; 2017 Aug; 28(4):355-360. PubMed ID: 28441156 [TBL] [Abstract][Full Text] [Related]
15. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Santos RD; Valenti L; Romeo S Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283 [TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. Mavromati M; Jornayvaz FR Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884625 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review. Oliveira CP; Stefano JT; Alvares-da-Silva MR Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):361-4. PubMed ID: 23639094 [TBL] [Abstract][Full Text] [Related]
18. Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu. Patel S; Siddiqui MB; Chandrakumaran A; Rodriguez VA; Faridnia M; Hernandez Roman J; Zhang E; Patrone MV; Kakiyama G; Walker C; Sima A; Minniti RJ; Boyett S; Bajaj JS; Sanyal A; Pandak WM; Bhati C; Siddiqui MS Dig Dis Sci; 2021 Jan; 66(1):263-272. PubMed ID: 32189102 [TBL] [Abstract][Full Text] [Related]
19. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Lim S; Oh TJ; Koh KK Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]